PCVX
#899
Vaxcyte, Inc. - Common Stock
66.8 0 USD
-0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-5.45%
Variación mensual
+11.89%
Variación en los últimos 6 meses
+6.44%
Cambio anual
+57.92%
Cierres anteriores
70.6 5
Open
70.2 8
Mínimo
66.6 3
Máximo
71.0 9
Financials
- Market Capitalization 9.94 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.vaxcyte.com
- Headquarter Delaware, United States
- FIGI BBG009PHHPL8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.2
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 874 |  IBRX ImmunityBio, Inc. - Common Stock | 9.80 USD | -3.16% | +3.38% | +17.79% | +290.44% | 10.39 B USD | ||
| 896 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.53 USD | -0.90% | +3.08% | +2.71% | +98.08% | 9.99 B USD | ||
| 922 |  KRYS Krystal Biotech, Inc. - Common Stock | 321.16 USD | -3.29% | -1.14% | -5.27% | +71.62% | 9.51 B USD | ||
| 950 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 138.49 USD | -4.41% | +0.84% | -6.10% | +84.33% | 8.96 B USD |